Close Menu
    What's Hot

    Athora’s Deal to Purchase Pension Insurance Corporation Receives Regulatory Approval

    March 9, 2026

    Kosmos Management Announces Seventh Asset-Backed Securitisation

    March 5, 2026

    Safeway Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

    March 5, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Athora’s Deal to Purchase Pension Insurance Corporation Receives Regulatory Approval

      March 9, 2026

      Safeway Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

      March 5, 2026

      US Competitive Pension Risk Transfer Cost Increased in January

      March 2, 2026

      Trinity Retirement Benefit Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      March 2, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026

      More UK Life Insurer Equity Release Securitisation on the Horizon?

      February 25, 2026

      Q&A: Dr. Joshua Funder, CEO and Managing Director, Household Capital

      February 25, 2026

      Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains

      February 11, 2026

      Athora’s Deal to Purchase Pension Insurance Corporation Receives Regulatory Approval

      March 9, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026

      Safeway Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

      March 5, 2026

      US Competitive Pension Risk Transfer Cost Increased in January

      March 2, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Debate Continues Over the Dangers of Vaping Versus Cigarette Smoking

    Mortality November 9, 2023By Aaron Woolner
    Share
    Twitter LinkedIn Email

    According to the World Health Organisation, there are approximately 1.3 billion global users of tobacco. Each year, eight million die – a number which includes more than one million passive smokers. Governments globally are trying to reduce the number of people smoking but they are dealing with the issue in different ways.  

    The UK introduced a ‘swap to stop’ scheme in April that allows smokers to exchange their cigarettes for an electronic substitute. Health Minister Neil O’Brien heralded the initiative as a global first in a speech announcing its introduction as the UK looks to cut cigarette use to less than 5% of the population by 2030.  

    Whereas a month later, Australia effectively banned vapes, restricting them to prescription only, with prohibition increasingly becoming the weapon of choice in fighting cigarette consumption. Over 20 of the 35 countries in the Americas have restricted the sale of vapes, including eight outright bans; an approach which has also been used in India, Japan, Thailand, and North Korea.  

    So, is vaping bad for users, or not? 

    According to Tracey Johnson, Underwriting and Claims Manager at UK-based MorganAsh, which provides support services to the financial sector, the question is complicated.  

    “It’s easy to get confused about whether vaping is dangerous or not. Because the simple answer is that we don’t really know what the long term impact of using a vape will be. Research published in 2015 by Public Health England states that it has previously been estimated that e-cigarettes are 95% safer than smoking cigarettes. And it also shows that vaping is a fantastic tool for people looking to get away from smoking.” 

    Despite this the insurance sector still treats vaping the same as smoking. According to Zurich UK, anyone who has used nicotine in the last 12 months – or up to five years in the case of some carriers – will be classified as a smoker by life insurers and charged premiums double that of a non-smoker.  

    The same is true in the US. In 2016, the country’s Food and Drug Administration (FDA), ruled that e-cigarettes were to be considered as tobacco products and therefore subject to federal regulation, putting vapes and cigarettes in the same category.  

    According to Monideepa Chetia, Vice President of Underwriting at Longevity Services Incorporated, the implication for life settlements providers is that they should equally take the same approach when looking at policies.   

    “Until long-term health studies prove or disprove that e-cigarettes and vapes are less harmful than traditional cigarettes, the best way to deal with this in underwriting is to consider it as smoking or consider debits on a case– to– case basis.”  

    Andrew Gethin, Managing Director at MorganAsh, says that despite the Public Health England report, in the absence of granular data and extensive studies into the long term impact of vaping, it is easier for insurers to take a safety first approach.  

    “It’s just simpler to go yes or no: you are either a smoker or a nonsmoker, and someone who uses nicotine is a smoker. It’s a bit crude, but it comes down to the practicalities of where you get the data and how you prove it’s correct.” 

    Gethin also says that an older person who now uses a vape, even if it’s intended as a bridge to non-smoking status, is still likely to have smoked for a long time and therefore have the associated health impairments. 

    “Traditionally, underwriting practice was to require someone to give up smoking for 12 months prior to moving to no smoker rates. If they move to vaping with nicotine, then they are still using nicotine and hence still qualified as a smoker. From a risk point of view the damage from years of smoking does not disappear overnight,” he says. 

    The UK government may view vapes as an effective method to get people to stop smoking but evidence suggests it is also an easy way for young people to acquire a nicotine habit.  

    This was noted by O’Brien in his speech announcing the swap to stop scheme. Describing vaping as a ‘double edged sword’, the health minister said an unwelcome result of vaping was its use by younger age groups. 

    “There has been a very sharp increase in children vaping – particularly disposable vapes. NHS figures for 2021 showed that 9% of 11– to– 15 year old children used e-cigarettes, up from 6% in 2018. That’s a rapidly rising trend we need to stop,” O’Brien said. 

    Vaping may be safer than smoking but it isn’t without risk. One danger is nicotine itself; its consumption impacts blood pressure and increases the likelihood of blood clots and can negatively impact adolescent brain development. 

    Vaping potentially brings entirely new risks with it. In 2019, there was an outbreak of a lung condition termed EVALI – an acronym for ‘e cigarette or vaping use association lung injury’ – which was tracked down to the use of vitamin E acetate in vapes.  

    It is presumed that this substance is no longer used in vapes but they still contain a number of potentially harmful additives. The American Lung Association reports that vapes typically include carcinogens such as: acetaldehyde and formaldehyde, and metals including; nickel, tin and lead and diacetyl.    

    “There are risks associated with vaping. But statistically, it’s better to vape than it is to smoke,” says Johnson. “That may change because there’s an enormous amount of data out there and more is coming in all of the time. Currently we don’t really know what the longer term effects are.” 

    Johnson says these long term effects will not become clear until there are 10 to 20 years’ worth of mortality data to demonstrate the dangers of vaping, and with the product only being available since the early 2000s, and in widespread use for a decade, it is currently too early to make a definitive call.  

    The long term impact of vaping may be unclear but according to Johnson it appears to be safer than cigarettes with regard to passive smoking.  

    When someone applies for a life insurance policy and declares themself a non-smoker, insurers can ask them to take a cotinine test, which looks for metabolites of nicotine present in urine or saliva and is usually presumed to indicate the person is a smoker.  

    Johnson says that is impossible to trigger this test via second hand vape smoke, whereas research shows that people who live in house with at least one smoker can often test positive for cotinine – and are therefore exposed to the dangers of second hand smoke.  

    “There is no statistical evidence to suggest that passive smoking is a risk to other people living in the same household as someone who is vaping. There may be small elements of nicotine, and other chemicals, in the exhaled smoke but it isn’t enough to impact someone else’s health.” 

    2023 - November Clinical Mortality Longevity Risk Mortality Risk Volume 2 Issue 11 - November 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Kosmos Management Announces Seventh Asset-Backed Securitisation

    March 5, 2026By LMI Newsdesk

    Safeway Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

    March 5, 2026By LMI Newsdesk

    US Competitive Pension Risk Transfer Cost Increased in January

    March 2, 2026By LMI Newsdesk

    Trinity Retirement Benefit Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    March 2, 2026By LMI Newsdesk
    Latest Issue

    Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains

    February 11, 2026

    US Plan Sponsors Are Turning to OCIOs for Buy-Out Readiness

    February 11, 2026

    Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

    February 11, 2026

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.